| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/05/2014 | CN103611149A Pentapeptide metabolite and application of pentapeptide metabolite in preparation of medicament for preventing and treating ischemic cerebrovascular diseases |
| 03/05/2014 | CN103073617B N-(2)-L-alanyl-L-glutamine compound |
| 03/05/2014 | CN102307890B Hepatitis c virus inhibitors |
| 03/04/2014 | US8664356 Gamma amino acid building blocks |
| 03/04/2014 | US8664355 Cell-free protein synthesis method with the use of linear template DNA and cell extract therefor |
| 02/27/2014 | WO2014030977A1 Pharmaceutical composition comprising, as active ingredients, peptides which exhibit inhibitory activity against angiotensin-i converting enzyme for preventing or treating cardiovascular diseases |
| 02/27/2014 | WO2014030950A1 Oyster hydrolysate-derived novel peptides having effects of inhibiting activity of collagenase, and use thereof |
| 02/27/2014 | WO2014030746A1 Acyl dipeptide derivative |
| 02/27/2014 | WO2014030597A1 Novel compound and method for producing same, novel microorganism, pharmaceutical composition, and anti-tumor agent |
| 02/27/2014 | WO2014029022A1 Fluorinated epoxyketone-based tetrapeptide compounds and uses thereof as proteasome inhibitors |
| 02/27/2014 | US20140057836 Hcv ns3 protease inhibitors |
| 02/27/2014 | US20140056964 Granzyme b inhibitor compositions, methods and uses for promoting wound healing |
| 02/27/2014 | US20140056855 Llp2a-bisphosphonate conjugates for osteoporosis treatment |
| 02/26/2014 | CN102807601B Aminoacyl-tryptophanyl-5-methoxytryptamine and preparation method and application thereof |
| 02/26/2014 | CN102796168B Compounds with thrombolytic activity and preparation method and application thereof |
| 02/26/2014 | CN102796165B Arg-Tyr modified aliphatic amine/ alcohol derivatives and preparation method and application thereof |
| 02/25/2014 | US8658764 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 02/25/2014 | US8658763 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 02/25/2014 | US8658762 Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof |
| 02/25/2014 | US8658434 Fluorescent pyrene compounds |
| 02/25/2014 | CA2532869C Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/25/2014 | CA2507936C Prion protein ligands and methods of use |
| 02/25/2014 | CA2207252C Inhibitors of prenyl transferases |
| 02/20/2014 | WO2014026282A1 Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors |
| 02/20/2014 | US20140051828 Methods for preparing internally constrained peptides and peptidomimetics |
| 02/20/2014 | US20140051633 Hepatocyte Growth Factor Mimics as Therapeutic Agents |
| 02/20/2014 | US20140051626 Antiviral compounds |
| 02/20/2014 | US20140050778 Nucleic acid binding compounds, methods of making, and use thereof |
| 02/19/2014 | EP2697249A1 Compounds binding to the bacterial beta ring |
| 02/19/2014 | EP2697246A1 Selective cysteine protease inhibitors and uses thereof |
| 02/19/2014 | CN103589529A Detergent composition |
| 02/19/2014 | CN103588863A Synthesis and preparation process of RGD cyclopeptide |
| 02/19/2014 | CN103588862A Synthesis and crystal form-transforming method of taltirelin |
| 02/19/2014 | CN103588861A New Delhi metallo-beta-lactamase inhibitory peptide and application thereof |
| 02/19/2014 | CN103588860A Preparation method of N-(2)-L-alanyl-L-glutamine sphaerocrystal |
| 02/19/2014 | CN102584938B Crystallizing method of aspartame |
| 02/19/2014 | CN101715484B Method for producing dipeptide |
| 02/18/2014 | US8653237 Peptide analogues |
| 02/18/2014 | US8653235 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 02/18/2014 | US8653234 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 02/18/2014 | US8653031 Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin—(1-7) |
| 02/18/2014 | US8652485 Peptide for vaccine |
| 02/18/2014 | US8652483 Viral infection enhancing peptide |
| 02/18/2014 | CA2783413C Kokumi-imparting agent |
| 02/18/2014 | CA2564076C Chemical linkers and conjugates thereof |
| 02/18/2014 | CA2451741C Peyers's patch and/or m-celle targeting ligands |
| 02/13/2014 | WO2014025023A1 METHOD FOR PRODUCING γ-GLUTAMYL-VALYL-GLYCINE CRYSTAL |
| 02/13/2014 | WO2013181584A3 Modulation of hepatitis b virus cccdna transcription |
| 02/13/2014 | WO2013040142A3 Bioinformatic processes for determination of peptide binding |
| 02/13/2014 | US20140045771 Novel dipeptidyl peptidase iv (dp-iv) compounds |
| 02/13/2014 | US20140045747 Methods for increasing and mobilizing hematopoietic stem cells |
| 02/13/2014 | US20140044689 Methods and compositions for preventing or treating ophthalmic conditions |
| 02/12/2014 | EP2695890A1 Process for producing reduced glutathione |
| 02/12/2014 | EP2694085A1 Methods of eradicating bacterial cell populations |
| 02/12/2014 | CN103582646A Antiviral agent |
| 02/12/2014 | CN103570804A Synthetic method of polypeptide with skin activity |
| 02/12/2014 | CN103570803A Preparation method of argatroban intermediate |
| 02/12/2014 | CN103570802A Chelate formed by glutathione and transition metal ions and application thereof |
| 02/12/2014 | CN103570603A Novel synthetic method of hemiasterlin |
| 02/12/2014 | CN102112486B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/11/2014 | US8648170 Peptide-presenting surfaces for long-term culture of pluripotent cells |
| 02/11/2014 | US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 02/11/2014 | US8647630 Mite allergen |
| 02/11/2014 | CA2529496C Anti-cd74 immunoconjugates and methods |
| 02/06/2014 | WO2014021389A1 Peptide capable of inhibiting mate activity |
| 02/06/2014 | WO2013184958A4 Chimeric fibroblast growth factor 21 proteins and methods of use |
| 02/06/2014 | US20140039155 Amyloid-beta peptide crystal structure |
| 02/06/2014 | US20140038910 Beta Amino Acid Derivatives as Integrin Antagonists |
| 02/06/2014 | US20140038903 Selective Cysteine Protease Inhibitors and Uses Thereof |
| 02/06/2014 | US20140038885 Macrocyclic Compounds and Methods for Their Production |
| 02/05/2014 | EP2691413A1 Macrocyclic compounds and methods for their production |
| 02/05/2014 | EP2691412A1 Macrocyclic compound and methods for its production |
| 02/05/2014 | EP2691370A1 Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma- glutamyl-l-tryptophan |
| 02/05/2014 | EP2691369A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan |
| 02/05/2014 | CN103561770A Lipoyl compounds and their use for treating ischemic injury |
| 02/05/2014 | CN103554222A Compounds for enzyme inhibition |
| 02/05/2014 | CN103554221A Method for preparing active peptides derived from snake venom |
| 02/05/2014 | CN103554220A Separation and purification method of oligopeptide before and after processing nacre mother |
| 02/05/2014 | CN103554219A Method for preparing bortezomib |
| 02/05/2014 | CN103554218A N(2)-L-alanyl-L-glutamine of new crystal forms, and preparation methods thereof |
| 02/05/2014 | CN103554143A Derivatives of 1-amino-2-cyclobutylethylboronic acid |
| 02/04/2014 | US8642729 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases |
| 02/04/2014 | US8642725 Process for production of peptide thioester |
| 02/04/2014 | US8642536 Method of making biologically active alpha-beta peptides |
| 02/04/2014 | CA2569553C Collections of traceable compounds and uses thereof |
| 01/30/2014 | WO2014018807A1 Peptide epoxyketone compounds |
| 01/30/2014 | WO2014015934A1 Hydroxystatin derivatives for treatment of arthrosis |
| 01/30/2014 | WO2013184794A3 Peripheral kappa receptor agonists for reducing pain and inflammation |
| 01/30/2014 | US20140031297 Compounds for enzyme inhibition |
| 01/30/2014 | US20140031277 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/30/2014 | US20140030221 Macrocyclic inhibitors of flaviviridae viruses |
| 01/30/2014 | US20140027655 Peptide nanostructures and methods of generating and using the same |
| 01/29/2014 | EP2688563A1 Gallium complexes, pharmaceutical compositions and methods of use |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN103539833A High-activity alpha-glucosidase inhibitory peptide and preparation method and application thereof |
| 01/29/2014 | CN103539832A Improved method of bortezomib process |
| 01/29/2014 | CN103539831A Prunus armeniaca alpha-glucosidase inhibiting peptide as well as preparation method and application of inhibiting peptide |
| 01/29/2014 | CN102796171B Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof |
| 01/29/2014 | CN102796170B Double saturated aliphatic chain alcohol His-Gly-Lys-Asp tetrapeptide esters and preparation method and application thereof |
| 01/29/2014 | CN102796169B Double saturated aliphatic chain alcohol Glu-Asp-Gly-Asp tetrapeptide esters and preparation method and application thereof |